Hodgkin lymphoma after autoimmune diseases by age at diagnosis and histological subtype

Annals of Oncology

Volumn 25, Issue 7, 2014, Pages 1397-1404

  Fallah, Mahdi ^a   Liu, X ^b   Ji, J ^b   Forsti A ^a,b   Sundquist, K ^b   Hemminki, K ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Autoimmune diseases; Hodgkin disease; Hodgkin lymphoma; Risk ratio

Indexed keywords

ADULT; AGE DISTRIBUTION; ANKYLOSING SPONDYLITIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; BEHCET DISEASE; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CELIAC DISEASE; CONTROLLED STUDY; CROHN DISEASE; DERMATOMYOSITIS; DISEASE ASSOCIATION; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HIGH RISK POPULATION; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE DEPLETION HODGKIN LYMPHOMA; LYMPHOCYTE-RICH CLASSICAL HODGKIN LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MIXED CELLULARITY HODGKIN LYMPHOMA; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NODULAR SCLEROSIS HODGKIN LYMPHOMA; PERNICIOUS ANEMIA; POLYARTERITIS NODOSA; POLYMYOSITIS; PRIORITY JOURNAL; PSORIASIS; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SARCOIDOSIS; SEX DIFFERENCE; SJOEGREN SYNDROME; STANDARDIZED INCIDENCE RATIO; SWEDEN; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS; WEGENER GRANULOMATOSIS; AGE; COMPLICATION; MIDDLE AGED;

AGE FACTORS; AUTOIMMUNE DISEASES; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; SWEDEN;

EID: 84903743961     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu144     Document Type: Article

References (33)

1. Kuppers R, Engert A, Hansmann ML. Hodgkin lymphoma. J Clin Invest 2012; 122:3439-3447.
2. Landgren O, Engels EA, Pfeiffer RM et al. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst 2006; 98: 1321-1330.
3. Anderson LA, Gadalla S, Morton LM et al. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer 2009; 125: 398-405.
4. Goldin LR, Landgren O. Autoimmunity and lymphomagenesis. Int J Cancer 2009; 124: 1497-1502.
5. Brown LM, Gridley G, Check D et al. Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood 2008; 111: 3388-3394.
6. Landgren AM, Landgren O, Gridley G et al. Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans. Cancer 2011; 117: 1163-1171.
7. Ekstrom Smedby K, Vajdic CM, Falster M et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 2008; 111: 4029-4038.
8. Hemminki K, Liu X, Ji J et al. Effect of autoimmune diseases on mortality and survival in subsequent digestive tract cancers. Ann Oncol 2012; 23: 2179-2184.
9. Hemminki K, Liu X, Ji J et al. Kaposi sarcoma and Merkel cell carcinoma after autoimmune disease. Int J Cancer 2012; 131: E326-E328.
10. Hemminki K, Liu X, Forsti A et al. Subsequent leukaemia in autoimmune disease patients. Br J Haematol 2013; 161: 677-687.
11. Liu X, Ji J, Forsti A et al. Autoimmune disease and subsequent urological cancer. J Urol 2013; 189: 2262-2268.
12. Hemminki K, Liu X, Ji J et al. Effect of autoimmune diseases on risk and survival in female cancers. Gynecol Oncol 2012; 127: 180-185.
13. Hemminki K, Liu X, Ji J et al. Effect of autoimmune diseases on risk and survival in histology-specific lung cancer. Eur Respir J 2012; 40: 1489-1495.
14. Hemminki K, Liu X, Forsti A et al. Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma. J Hematol Oncol 2012; 5: 59.
15. Bei R, Masuelli L, Palumbo C et al. A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth. Cancer Lett 2009; 281: 8-23.
16. Vajdic CM, van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer 2009; 125: 1747-1754.
17. Rothwell PM, Price JF, Fowkes FG et al. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 2012; 379:1602-1612.
18. Rothwell PM, Fowkes FG, Belch JF et al. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011; 377: 31-41.
19. Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program 2009; 523-531.
20. Campo E, Swerdlow SH, Harris NL et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 2011; 117: 5019-5032.
21. Townsend W, Linch D. Hodgkin's lymphoma in adults. Lancet 2012; 380:836-847.
22. Hawkes EA, Wotherspoon A, Cunningham D. The unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: current approaches to diagnosis and management. Leuk Lymphoma 2012; 53: 354-361.
23. Amur S, Parekh A, Mummaneni P. Sex differences and genomics in autoimmune diseases. J Autoimmun 2011; 38: J254-J265.
24. Quintero OL, Amador-Patarroyo MJ, Montoya-Ortiz G et al. Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun 2012; 38: J109-J119.
25. Hemminki K, Li X, Sundquist K et al. Familial association of inflammatory bowel diseases with other autoimmune and related diseases. Am J Gastroenterol 2010; 105: 139-147.
26. Mercer LK, Davies R, Galloway JB et al. Risk of cancer in patients receiving nonbiologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population. Rheumatology (Oxford) 2013; 52: 91-98.
27. Ferlay J, Shin HR, Bray F et al. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France:International Agency for Research on Cancer, 2010.
28. Kuppers R, Rajewsky K, Zhao M et al. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA 1994; 91: 10962-10966.
29. LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood 2008; 112: 1570-1580.
30. Miller EB. Hodgkin lymphoma and autoimmunity: a two-way street. Clin Adv Hematol Oncol 2012; 10: 276-277.
31. Lossius A, Johansen JN, Torkildsen O et al. Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis-association and causation. Viruses 2013; 4: 3701-3730.
32. Hjalgrim H. On the aetiology of Hodgkin lymphoma. Dan Med J 2012; 59: B4485.
33. Thorsby E, Lie BA. HLA associated genetic predisposition to autoimmune diseases:genes involved and possible mechanisms. Transpl Immunol 2005; 14: 175-182.